Pravastatin Sodium Tablet
Product Images NDC 82868-091

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 82868-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 091 30 Rev A 10 25.jpg)

Pravastatin Sodium Tablets, USP 20 mg tablet label showing the product name, strength, dosage form, and package size of 30 tablets. The label includes storage instructions, handling precautions, prescription status (Rx Only), and repackaging information by Northwind Pharmaceuticals and Northwind Health Company, LLC.*

FDA Label Image

Figure 1 (Pravastatin Fig1)

A survival distribution graph comparing the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction over five years since randomization. The graph shows two lines representing placebo and pravastatin groups, illustrating differences in survival proportions with a logrank P-value of 0.0001.*

FDA Label Image

Chemical Struture (Pravastatin Str)

Chemical structure of pravastatin sodium. The molecular diagram illustrates the arrangement of atoms and bonds characteristic of pravastatin sodium, consistent with its identity as an active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.